Rivo Bio is leading the discovery of next generation small molecule CNS therapeutics through an integrative network medicine-based approach, designed to unlock the complexity of neurodisorders, accelerate discovery, and de-risk therapeutic outcomes. We move beyond traditional approaches by leveraging innovations in multitarget discovery and modulation, harnessing network effects for greater therapeutic impact. Our approach is set to transform how treatments are developed, to deliver life-changing solutions to patients in need.
Rivo’s primary objective is to fundamentally improve neurohealth by redefining how treatments are discovered, challenging traditional approaches to unlock and deliver new therapeutic possibilities.
Rivo - Latin for stream. A constant, evolving flow of consciousness.
Please email for collaboration or investment inquiry.